Clinical Trial Update: Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI) [NA]

View source ↗

Summary

A clinical trial update for SCOUT Echo-AI, a screening study using echocardiography AI to explore cardiometabolic opportunities in MASLD and cirrhosis; recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: Kaiser Permanente | Conditions: MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Cirrhosis | NA | Status: NOT_YET_RECRUITING